CS
ERNAW

Clear Street’s Ernexa Therapeutics Warrants ERNAW Stock Holding History

Clear Street’s Portfolio ERNAW Stock Details ERNAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7K Buy
149,499
+199
+0.1% +$19 ﹤0.01% 1207
2026
Q1 		$4.18K Buy
+149,300
New +$8.84K ﹤0.01% 1014

Other funds holding ERNAW

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Clear Street's ERNAW Position: Q2 2026 in Review

Clear Street increased its Ernexa Therapeutics Warrants (ERNAW) stake by 0.13% in Q2 2026, buying an estimated $19 and bringing the position to 149,499 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1207.

Clear Street first reported a position in ERNAW in Q1 2026 and has held it in 2 quarters since. 6 funds tracked by Wall St. Rank hold ERNAW as of Q2 2026.

  • Clear Street held 149,499 shares of Ernexa Therapeutics Warrants worth $10.7K as of Q2 2026.
  • Clear Street bought 199 Ernexa Therapeutics Warrants shares in Q2 2026, an estimated $19.
  • Ernexa Therapeutics Warrants made up ﹤0.01% of Clear Street's portfolio in Q2 2026, its #1207 holding.
  • Clear Street first reported a position in Ernexa Therapeutics Warrants in Q1 2026 and has held it in 2 quarters since.
  • 6 funds tracked by Wall St. Rank held Ernexa Therapeutics Warrants as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.